John W. Henson, MD
Dr. Henson practices neuro-oncology in the MCG Brain Tumor Program and manages patients with neurofibromatosis, tuberous sclerosis, von Hippel-Lindau and related genetic disorders in the MCG Neurofibromatosis Clinic. He has a broad clinical interest in hereditary cancer risk analysis and risk reduction and started the Hereditary Cancer Clinic at the Georgia Cancer Center. Dr. Henson trained in neurology at Vanderbilt University Medical Center and in neuro-oncology at Memorial Sloan-Kettering Cancer Center. He was director of the MGH Brain Tumor Center in Boston for many years, and also served as Chief of Oncology Services for Piedmont Healthcare, based in Atlanta. Dr. Henson studied genomic cancer risk assessment with Dr. Jeffrey Weitzel at City of Hope. Most recently he was medical director of the Ivy Center for Advanced Brain Tumor Treatment and Swedish Neurofibromatosis Center at Swedish Medical Center in Seattle. He is coauthor of the textbook Diagnosis and Management of Hereditary Cancer and has published over 150 papers, reviews, and books chapters.
Co-author of the 2021 textbook, Diagnosis and Management of Hereditary Cancer.
I strive to reduce the impact of cancer.
Director, MCH Brain Tumor Program
Director, Hereditary Cancer Clinic
Professor of Neurology, Medicine, and Neurosurgery
Diplomate, American Board of Psychiatry and Neurology - Certified
Fellowship: Memorial Sloan-Kettering Cancer Center
Resources & Tools.